Lincoln Pharmaceuticals Ltd - Due diligence report

A 360° intelligence report on Lincoln Pharma: trust score, financial health, credit view, compliance, directors, growth and distress signals…

1995-01-20 Ahmedabad, Gujarat Active Listed Active Compliant
Share
LP Lincoln Pharmaceuticals Ltd
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Lincoln Pharma — 360° Intelligence Report

Generated from MCA filings & public records
75/100
Trust Score
Low Risk

Lincoln Pharma is assessed as Low Risk with a Trust Score of 75/100. Lincoln Pharma is an active public limited indian non-government company incorporated in 1995, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Lincoln Pharmaceuticals Ltd snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
75/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
32/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Consolidated · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 2 open (117.64 cr) · 4 satisfied (47.00 cr).

Banking relationships (from registered charges)
LenderChargesAmount
State Bank Of India2 48.0 cr
Yes Bank Limited2 48.0 cr
Idbi Bank Limited1 48.0 cr
Icici Bank Ltd.1 48.0 cr
Compliance Score: 32/100 Caution Indicated
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Flagged by authority: DSE.
  • Litigation present in 5 court forum(s).
  • 1 auditor resignation(s) filed - latest: CHANDULAL M. SHAH AND CO. on 2015-06-25.
  • Delayed payments to MSME suppliers disclosed (86 disclosure(s)).
  • 1 active GST registration(s).
Legal cases on record (5)
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
MUNJAL MAHENDRABHAI PATEL 01234567 Director 01/04/2018 6 yrs Approved
DARSHIT ASHVINKUMAR SHAH 01234567 Director 01/04/2018 6 yrs Approved
TRUSHA ATULKUMAR SHAH 01234567 Director 01/04/2018 6 yrs Approved
NARESHKUMAR PIRABHAI SUTHAR 01234567 Director 01/04/2018 6 yrs Approved
Seema Manubhai Mehta 01234567 Director 01/04/2018 6 yrs Approved
MAHENDRABHAI GULABDAS PATEL 01234567 Director 01/04/2018 6 yrs Approved
KISHOR MEGHJI SHAH 01234567 Director 01/04/2018 6 yrs Approved
SAURIN JAGDISH BHAI PARIKH 01234567 Director 01/04/2018 6 yrs Approved
ASHISH RAJANIKANT PATEL 01234567 Director 01/04/2018 6 yrs Approved
RAJANIKANT GULABDAS PATEL 01234567 Director 01/04/2018 6 yrs Approved
HASHMUKHBHAI ISHWARLAL PATEL 01234567 Director 01/04/2018 6 yrs Approved
Darshit Ashvinkumar Shah 01234567 Director 01/04/2018 6 yrs Approved
  • 12 directors on the board.
  • No disqualified or deactivated DINs.
  • 3 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Key managerial personnel: MUNJAL MAHENDRABHAI PATEL (Whole-time director) · DARSHIT ASHVINKUMAR SHAH (CFO) · MAHENDRABHAI GULABDAS PATEL (Managing Director) · ASHISH RAJANIKANT PATEL (Whole-time director) · HASHMUKHBHAI ISHWARLAL PATEL (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 75 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 31+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Compliance score is weak (32/100).
2 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 86.00 Lakh.
5 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence62/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment79/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 117.64 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view82/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
17 May 2024
Director ceased
NARESHKUMAR PIRABHAI SUTHAR
Director ceased
Seema Manubhai Mehta
01 Apr 2024
Director appointed
NARESHKUMAR PIRABHAI SUTHAR (Director)
Director appointed
Seema Manubhai Mehta (Director)
31 Mar 2024
Director ceased
PIRABHAI RAMJIBHAI SUTHAR
04 Dec 2022
Director ceased
ISHWARLAL AMBALAL PATEL
16 Nov 2022
Director appointed
TRUSHA ATULKUMAR SHAH (Company Secretary)
Director ceased
NIREN ATINBHAI DESAI
09 Aug 2022
Director ceased
ARVINDBHAI GULABDAS PATEL
Director ceased
ANAND ARVINDBHAI PATEL
29 Apr 2021
Charge satisfied
Yes Bank Limited
20 Sep 2019
Charge satisfied
Yes Bank Limited
28 Mar 2019
Director appointed
DARSHIT ASHVINKUMAR SHAH (CFO)
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
12 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Omya U24110MH2004PTC149843 Taloja, Maharashtra, India
Malladi U24230TN1980PLC008382 Chennai, Tamil Nadu, India
Shreyans Industries L17115PB1979PLC003994 Ludhiana, Punjab, India
Quaker U24100WB1997PTC084645 Kolkata, West Bengal, India
Amines & Plasticizers L24229AS1973PLC001446 Guwahati, Assam, India
Aarti Surfactants L24100MP2018PLC067037 Dhar, Madhya Pradesh, India
Ultramarine & Pigments L24224MH1960PLC011856 Mumbai, Maharashtra, India
Rpg Life Sciences L24232MH2007PLC169354 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Lincoln Pharma before audits and certifications: compliance score 32/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Lincoln Pharma: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 75/100, margin trends, ownership structure and peer set for Lincoln Pharma - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 75/100, distress signals and MSME payment-delay disclosures - know whether Lincoln Pharma pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (5 case(s) on record), regulatory flags, charge documents trail and director networks for Lincoln Pharma - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Lincoln Pharma an active company?

Lincoln Pharma has MCA status “Active” with a compliance score of 32/100 (Caution Indicated).

Is Lincoln Pharma financially healthy?

Lincoln Pharma has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Lincoln Pharma?

Its overall Trust Score is 75/100 (Low Risk). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Lincoln Pharma?

See the directors and ownership sections above for board and shareholding detail. 12 active director(s) are on record.

Does Lincoln Pharma have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 4 earlier charge(s) stand satisfied.

Is Lincoln Pharma up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 32/100 (Caution Indicated).

Is it risky to lend to Lincoln Pharma?

Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.